Stay updated on Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a background update to the site tooling rather than any change to the clinical trial information.SummaryDifference0.0%

- Check27 days agoChange Detected- Updated the revision tag from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check55 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131. The page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check70 days agoChange Detected- Revision: v3.4.3 was applied to the page, replacing the previous v3.4.2.SummaryDifference0.0%

- Check92 days agoChange DetectedAdded the study condition 'Gastric cancer' and a new resource link to the Genetic and Rare Diseases Information Center; Updated the page revision to v3.4.2, replacing v3.4.1.SummaryDifference0.1%

- Check99 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1. No substantive study-related content appears to have changed.SummaryDifference0.0%

Stay in the know with updates to Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.